Home › Research › OKLO
OKLO: business model, Q2 2026 update, and the bull and bear case
Research note · Updated Oct 9, 2026
Oklo Inc. (NYSE: OKLO) is developing small advanced fission power plants called Aurora powerhouses, targeting data centers, defense sites, and industrial customers. Its first reactor — the Groves isotope facility — achieved first criticality in August 2026. Commercial power revenue is still roughly two years away. The company holds $3 billion in cash and carries a market cap of roughly $8 billion.
$1.2MQ2 2026 revenue (first-ever)
$3.0Bcash & securities on hand
2028Aurora-INL commercial target
1.2 GWMeta Ohio campus by 2034
What Oklo does
Oklo builds Aurora powerhouses — fast-fission, liquid-metal-cooled small modular reactors (SMRs) producing up to 75 megawatts electric (MWe). The business model has three parts:
- Power purchase agreements (PPAs): Oklo builds and operates reactors, then sells electricity to customers under long-term contracts. Customers include data centers (Meta), defense facilities, and industrial sites.
- Used nuclear fuel recycling: Aurora reactors can run on recycled spent nuclear fuel — a genuine differentiator. The U.S. has accumulated over 100,000 metric tons of used fuel. Oklo is pursuing a commercial recycling facility.
- Radioisotopes (Atomic Alchemy): The Groves reactor produces medical and research radioisotopes as a near-term revenue stream while power plants are licensed and built.
The company does not sell reactors — it retains ownership and sells electrons and isotopes, more like a utility than a manufacturer.
Q2 2026 financial update
| Metric | Q2 2026 | Q1 2026 | Note |
|---|---|---|---|
| Revenue | $1.2M | $0 | First-ever revenue; crushed $77K estimate by 16x |
| Net loss | ($48.5M) | ($32.5M) | Loss widening as R&D scales up |
| R&D expense (6-month) | $66.5M | — | +244% year-over-year |
| G&A expense (6-month) | $58.1M | — | +119% year-over-year |
| Cash & marketable securities | $3.0B | $1.1B | $1.9B added in H1 via equity raises |
| EPS (non-GAAP) | ($0.28) | ($0.19) | Missed $0.16 estimate by $0.12 |
| Shares outstanding | 174M | ~155M | Growing via equity issuances |
Source: Oklo 10-Q, June 30, 2026 (SEC EDGAR); Q2 earnings summary. Not investment advice.
Key milestones
| Date | Milestone |
|---|---|
| Jul 1, 2026 | DOE Final Safety Analysis approved for Groves reactor |
| Jul 23, 2026 | DOE startup authorization granted for Groves — cleared for fuel loading |
| Aug 6, 2026 | First criticality achieved at Groves isotope reactor — first Oklo reactor operating |
| Aug 7, 2026 | Q2 2026 earnings reported |
| Jun 2026 | Centrus LOI signed: nuclear fuel for Aurora-INL and Ohio campus |
| Jun 2026 | Strategic alliance with Standard Nuclear for fuel supply chain |
| Early 2026 | Meta deal: 1.2 GW Ohio power campus targeting 2034 full capacity |
| Apr 2026 | NVIDIA + Los Alamos collaboration on AI-enabled reactor design |
| 2028 (target) | Aurora-INL commercial startup — first power revenue |
Bull case
- First mover with a running reactor. Groves is the only advanced-fission reactor currently operating in the U.S. That is real-world experience no competitor has yet.
- $3 billion war chest. At the current burn rate (~$130M per half-year in operating cash), Oklo has roughly 10+ years of runway before it needs to raise again.
- Used-fuel recycling moat. If the recycling business works, Oklo gets a nearly free fuel supply while competitors pay market rates. No other company has a credible commercial path to this.
- AI power demand is structural. Data centers need gigawatts of reliable, low-carbon power. The Meta deal is one example of what could be a long pipeline.
- Policy tailwind. Multiple executive orders have accelerated advanced nuclear permitting. DOE and NRC processes that used to take a decade are being compressed.
- Analyst conviction. Canaccord Genuity initiated with a Buy rating and a $175 price target in October 2026.
Bear case
- No commercial power revenue until 2028 at the earliest. Aurora-INL is the first planned power plant. Everything before that is pre-revenue.
- Spending is accelerating fast. R&D and G&A grew 244% and 119% year-over-year in H1 2026. The loss widened even as revenue appeared for the first time.
- EPS misses every quarter. Oklo missed consensus EPS in Q2 2025, Q3 2025, Q4 2025, and Q2 2026. The one quarter it hit was Q1 2026.
- Share dilution is ongoing. The $1.9 billion raised in H1 2026 came from new equity. Shareholders are being diluted each time.
- NRC licensing risk is real. NuScale Power had its small modular reactor design certified by the NRC in 2022, then cancelled its only project in 2023 after cost overruns. Oklo has not yet received a construction permit for an Aurora powerhouse.
- Stock is down ~47% year-to-date as of October 2026, off a 52-week high of $193. The market has already repriced the optimism once.
- Competition is intensifying. Standard Nuclear is already producing commercial TRISO fuel. NANO Nuclear's KRONOS has entered formal NRC review. New entrants are appearing regularly.
What to watch next
- NRC construction permit for Aurora-INL — the single most important regulatory milestone
- Q3 2026 earnings (~Nov 10, 2026): whether Groves isotope revenue scales meaningfully
- Conversion of non-binding LOIs into signed power purchase agreements
- Fuel fabrication license progress with INL
Sources: Oklo 10-Q (Q2 2026), Q2 earnings coverage, S&P Global analyst estimates, Oklo press release timeline, Meta/Ohio campus announcement. Updated Oct 9, 2026. Not investment advice.